Nanosonics Limited (AU:NAN) has released an update.
Nanosonics Limited, an Australian infection prevention company, is revolutionizing the safety standards in healthcare with its innovative trophon technology, which has become a global standard for ultrasound probe disinfection. The company boasts a significant global presence, with over 34,000 trophon units installed, protecting approximately 27 million patients annually from cross-contamination risks. Nanosonics continues to invest in research and development to broaden its product range and reinforce its commitment to advancing infection prevention.
For further insights into AU:NAN stock, check out TipRanks’ Stock Analysis page.
